Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy

Dariela Micheloud, L Nuño, Margarita Rodríguez‐Mahou, Silvia Sánchez‐Ramón, Mayra Ortega, Á. Aguarón, E Junco, Javier Carbone, Eduardo Fernández‐Cruz, Luis Carreño,

Lupus · 2006 · 49 citations · 26 references

Concepts

Abstract

We report one case of pregnancy-onset severe diffuse proliferative nephritis in a patient with systemic lupus erythematosus (SLE), who was successfully treated with a combination of anti-tumour necrosis factor (TNF)-alpha, plasmapheresis and high-dose intravenous gammaglobulin. No flares were observed either in clinical symptoms or in laboratory examinations during pregnancy or after delivery. Her autoantibodies except fluorescent anti-nuclear antibodies were negative. We suggest that a combination of anti-TNF-alpha, plasmapheresis and high-dose intravenous gammaglobulin may be a safe and effective therapy for pregnant patients suffering severe lupus nephritis.

References

26